Implementation of the Child Housing Assessment for a Safe Environment
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Jun 1, 2023
Trial Information
Current as of July 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
To address the gap between known preventative factors for child home injuries and the uptake of those prevention approaches by high-risk families, the hazards must be systematically and rigorously assessed, and modifications properly implemented and evaluated. Although there are standardized approaches to assess and address particular home health hazards, such as lead paint, asthma, there is no standard tool for injury control. The study team has developed and tested a tool to assess child injury risks in the home (CHASE Tool). The study team has adapted the existing CHASE tool, found in th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent or guardian (or an emancipated minor who meets all other inclusion criteria) whose household is participating in either the GHHI DSS Foster Care Homes Program (FCHP) OR GHHI Amerigroup Maryland Asthma Program (AMAP)
- • Households with at least one child under 7 years of age, or foster care families planning to host a child under 7
- • The child under 7 years of age lives with the parent or legal guardian most of the time
- • Income at or below 80% AMI as defined by US Department of Housing and Urban Development (HUD)
- • A home address in Baltimore City or Baltimore County
- Exclusion Criteria:
- • Parent or guardian whose household is participating is not in either the GHHI DSS Foster Care Homes Program (FCHP) OR GHHI Amerigroup Maryland Asthma Program (AMAP)
- • Household does not have at least one child under 7 years of age, or foster care families are not planning to host a child under 7
- • The child under 7 years of age does not live with the parent or legal guardian most of the time
- • Income is not at or below 80% AMI as defined by HUD
- • The home address is not in Baltimore City or Baltimore County
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Wendy Shields, PhD
Principal Investigator
Johns Hopkins Center for Injury Research and Policy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported